What Is Beam Therapeutics Inc. (BEAM) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Beam Therapeutics Inc.'s intrinsic value is estimated at $12.68, suggesting the stock is overvalued at its current price of $30.89. With 11 out of 12 models flagging downside (-59.0% average return), the market may be pricing in unsustainable growth. Notably, PWERM sees the most upside at +15.3% (fair value: $35.60), while Sentiment SOTP is the most conservative at -96.1% ($1.19). The spread between these extremes — +111.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About BEAM?
12 of 13 models are currently active for BEAM. Of these, 1 model suggests upside while 11 models suggest overvaluation. The Bayesian DCF estimates BEAM's intrinsic value at $11.31, implying -63.4% downside from the current price. See which stocks rank higher →
How Does BEAM Rank in Biological Products, (No Diagnostic Substances)?
Among 145 Biological Products, (No Diagnostic Substances) stocks, BEAM ranks #15 by Quality of Company score. CirclFi's QOC score of 7.2/10 evaluates 32 fundamental signals. A score of 7.2 indicates above-average quality.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Beam Therapeutics Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BEAM a Value Trap?
CirclFi's Value Trap algorithm assigns BEAM a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Beam Therapeutics Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Beam Therapeutics Inc.'s fundamental quality profile registers 7.2/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +111.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BEAM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BEAM's 12 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad